ITMI20042475A1 - Uso di derivati tiazolidinonici come agenti terapeutici - Google Patents
Uso di derivati tiazolidinonici come agenti terapeuticiInfo
- Publication number
- ITMI20042475A1 ITMI20042475A1 IT002475A ITMI20042475A ITMI20042475A1 IT MI20042475 A1 ITMI20042475 A1 IT MI20042475A1 IT 002475 A IT002475 A IT 002475A IT MI20042475 A ITMI20042475 A IT MI20042475A IT MI20042475 A1 ITMI20042475 A1 IT MI20042475A1
- Authority
- IT
- Italy
- Prior art keywords
- sub
- thiazolidinonic
- derivatives
- therapeutic agents
- 1alpha
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT002475A ITMI20042475A1 (it) | 2004-12-23 | 2004-12-23 | Uso di derivati tiazolidinonici come agenti terapeutici |
AU2005318432A AU2005318432A1 (en) | 2004-12-23 | 2005-12-19 | Use of thiazolidinone derivatives as antiangiogenic agents |
CNA2005800440053A CN101083989A (zh) | 2004-12-23 | 2005-12-19 | 噻唑烷酮衍生物作为抗血管生成剂的用途 |
CA002592004A CA2592004A1 (en) | 2004-12-23 | 2005-12-19 | Use of thiazolidinone derivatives as antiangiogenic agents |
DE602005018390T DE602005018390D1 (de) | 2004-12-23 | 2005-12-19 | Verwendung von thiazolidinon-derivaten zur behandlung von festen tumoren |
MX2007007498A MX2007007498A (es) | 2004-12-23 | 2005-12-19 | Uso de derivados de tiazolidinona como agentes antiangiogenicos. |
EP05820657A EP1830848B1 (en) | 2004-12-23 | 2005-12-19 | Use of thiazolidinone derivatives for the treatment of solid tumors |
JP2007547309A JP2008525340A (ja) | 2004-12-23 | 2005-12-19 | 抗血管新生薬としてのチアゾリジノン誘導体の使用 |
AT05820657T ATE451922T1 (de) | 2004-12-23 | 2005-12-19 | Verwendung von thiazolidinon-derivaten zur behandlung von festen tumoren |
ZA200704914A ZA200704914B (en) | 2004-12-23 | 2005-12-19 | Use of Thiazolidinone derivatives as antiangiogenic agents |
PCT/EP2005/013650 WO2006066846A1 (en) | 2004-12-23 | 2005-12-19 | Use of thiazolidinone derivatives as antiangiogenic agents |
KR1020077014023A KR20070100718A (ko) | 2004-12-23 | 2005-12-19 | 티아졸리디논 유도체의 혈관형성 억제제로서의 용도 |
US11/793,874 US20080261980A1 (en) | 2004-12-23 | 2005-12-19 | Use of Thiazolidinone Derivatives as Antiangiogenic Agents |
IL184116A IL184116A0 (en) | 2004-12-23 | 2007-06-21 | Use of thiazolidinone derivatives as antiangiogenic agents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT002475A ITMI20042475A1 (it) | 2004-12-23 | 2004-12-23 | Uso di derivati tiazolidinonici come agenti terapeutici |
Publications (1)
Publication Number | Publication Date |
---|---|
ITMI20042475A1 true ITMI20042475A1 (it) | 2005-03-23 |
Family
ID=36168693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT002475A ITMI20042475A1 (it) | 2004-12-23 | 2004-12-23 | Uso di derivati tiazolidinonici come agenti terapeutici |
Country Status (14)
Country | Link |
---|---|
US (1) | US20080261980A1 (it) |
EP (1) | EP1830848B1 (it) |
JP (1) | JP2008525340A (it) |
KR (1) | KR20070100718A (it) |
CN (1) | CN101083989A (it) |
AT (1) | ATE451922T1 (it) |
AU (1) | AU2005318432A1 (it) |
CA (1) | CA2592004A1 (it) |
DE (1) | DE602005018390D1 (it) |
IL (1) | IL184116A0 (it) |
IT (1) | ITMI20042475A1 (it) |
MX (1) | MX2007007498A (it) |
WO (1) | WO2006066846A1 (it) |
ZA (1) | ZA200704914B (it) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1916249A1 (en) * | 2006-10-10 | 2008-04-30 | LEK Pharmaceuticals D.D. | 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents |
FR2929851B1 (fr) * | 2008-04-09 | 2012-11-30 | Centre Nat Rech Scient | Molecules inhibant une voie metabolique impliquant la proteine tyrosine kinase syk et procede d'identification de ces molecules |
US8236838B2 (en) | 2008-04-21 | 2012-08-07 | Institute For Oneworld Health | Compounds, compositions and methods comprising isoxazole derivatives |
WO2009131957A2 (en) | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, compositions and methods comprising oxadiazole derivatives |
MY160004A (en) * | 2008-11-14 | 2017-02-15 | Bayer Ip Gmbh | Heterocyclically substituted aryl compounds as hif inhibitors |
US8343976B2 (en) | 2009-04-20 | 2013-01-01 | Institute For Oneworld Health | Compounds, compositions and methods comprising pyrazole derivatives |
AR078770A1 (es) | 2009-10-27 | 2011-11-30 | Elara Pharmaceuticals Gmbh | Derivados de dihidrobenzo oxacinas y tiazinas, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades inflamatorias e hiperproliferativas. |
WO2015023827A1 (en) * | 2013-08-14 | 2015-02-19 | North Carolina Central University | A high-throughput assay for identifying small molecules that modulate amp-activated protein kinase (ampk) |
CA2988584C (en) * | 2015-06-12 | 2024-01-23 | Adhaere Pharmaceuticals, Inc. | Solid forms of (z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid |
WO2021061665A1 (en) * | 2019-09-23 | 2021-04-01 | Gb006, Inc. | Integrin agonist prodrugs |
WO2024037910A1 (en) * | 2022-08-17 | 2024-02-22 | Institut National de la Santé et de la Recherche Médicale | Syk inhibitors for use in the treatment of cancer |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE794532A (fr) * | 1972-01-26 | 1973-07-25 | Boehringer Sohn Ingelheim | Nouvelles 3-hydroxymethyl-5-benzylidene-azolidinones et procede pour les fabriquer |
AU7684798A (en) * | 1997-05-30 | 1998-12-30 | Texas Biotechnology Corporation | Compounds that inhibit the binding of vascular endothelial growth factor to its receptors |
JPH11302280A (ja) * | 1998-04-17 | 1999-11-02 | Ono Pharmaceut Co Ltd | チアゾリジン誘導体、およびその誘導体を有効成分とする医薬 |
US6706766B2 (en) * | 1999-12-13 | 2004-03-16 | President And Fellows Of Harvard College | Small molecules used to increase cell death |
US20040002526A1 (en) * | 2002-04-03 | 2004-01-01 | Cell Therapeutics, Inc. | Phospholipase D inhibitors and uses thereof |
US7220764B2 (en) * | 2002-06-17 | 2007-05-22 | The Pennsylvania State University Research Foundation | Sphingosine kinase inhibitors |
BR0203747A (pt) * | 2002-09-10 | 2004-05-25 | Conselho Nacional Cnpq | Moléculas com atividade antitumoral e processo para a sua obtenção |
EP1551396A1 (en) * | 2002-09-26 | 2005-07-13 | Pintex Pharmaceuticals, Inc. | Pin1-modulating compounds and methods of use thereof |
US20060276520A1 (en) * | 2002-11-13 | 2006-12-07 | Rigel Pharmaceuticals, Inc. | Rhodanine derivatives and pharmaceutical compositions containing them |
DE602004025708D1 (de) * | 2003-07-11 | 2010-04-08 | Proteologics Inc | Ubiquitin-ligase-hemmer und verwandte verfahren |
WO2005016227A2 (en) * | 2003-08-14 | 2005-02-24 | Insight Biopharmaceuticals Ltd. | Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof |
WO2005026127A1 (ja) * | 2003-09-11 | 2005-03-24 | Institute Of Medicinal Molecular Design. Inc. | プラスミノゲンアクチベータインヒビター-1阻害剤 |
US20050282840A1 (en) * | 2004-02-11 | 2005-12-22 | Painceptor Pharma Corporation | Methods of modulating neurotrophin-mediated activity |
-
2004
- 2004-12-23 IT IT002475A patent/ITMI20042475A1/it unknown
-
2005
- 2005-12-19 WO PCT/EP2005/013650 patent/WO2006066846A1/en active Application Filing
- 2005-12-19 EP EP05820657A patent/EP1830848B1/en active Active
- 2005-12-19 ZA ZA200704914A patent/ZA200704914B/xx unknown
- 2005-12-19 JP JP2007547309A patent/JP2008525340A/ja active Pending
- 2005-12-19 AT AT05820657T patent/ATE451922T1/de not_active IP Right Cessation
- 2005-12-19 US US11/793,874 patent/US20080261980A1/en not_active Abandoned
- 2005-12-19 CN CNA2005800440053A patent/CN101083989A/zh active Pending
- 2005-12-19 DE DE602005018390T patent/DE602005018390D1/de not_active Expired - Fee Related
- 2005-12-19 AU AU2005318432A patent/AU2005318432A1/en not_active Abandoned
- 2005-12-19 KR KR1020077014023A patent/KR20070100718A/ko not_active Application Discontinuation
- 2005-12-19 MX MX2007007498A patent/MX2007007498A/es not_active Application Discontinuation
- 2005-12-19 CA CA002592004A patent/CA2592004A1/en not_active Abandoned
-
2007
- 2007-06-21 IL IL184116A patent/IL184116A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1830848B1 (en) | 2009-12-16 |
IL184116A0 (en) | 2007-10-31 |
ATE451922T1 (de) | 2010-01-15 |
DE602005018390D1 (de) | 2010-01-28 |
EP1830848A1 (en) | 2007-09-12 |
WO2006066846A1 (en) | 2006-06-29 |
KR20070100718A (ko) | 2007-10-11 |
CA2592004A1 (en) | 2006-06-29 |
ZA200704914B (en) | 2008-10-29 |
JP2008525340A (ja) | 2008-07-17 |
US20080261980A1 (en) | 2008-10-23 |
AU2005318432A1 (en) | 2006-06-29 |
CN101083989A (zh) | 2007-12-05 |
MX2007007498A (es) | 2007-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL184116A0 (en) | Use of thiazolidinone derivatives as antiangiogenic agents | |
ATE452129T1 (de) | N-phenyl-2-pyrimidine-amine derivatives | |
DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren | |
NO20060981L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
ATE361287T1 (de) | Neue indol-2-on derivate | |
TNSN03110A1 (en) | Azaindoles. | |
MXPA03005464A (es) | Agentes antivirales. | |
BRPI0409227B8 (pt) | "composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)" | |
HK1062677A1 (en) | 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
PT1404347E (pt) | Nucleosidos 4'-substituidos para o tratamento de doencas mediadas pelo virus da hepatite c | |
SE0101387D0 (sv) | Novel compounds | |
MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
DE602005002562D1 (de) | Pyrrolylsubstituierte pyridoä2,3-düpyrimidin-7-one und derivate davon als therapeutische mittel | |
IS6520A (is) | Ný efnasambönd | |
SE0402762D0 (sv) | Indazole sulphonamide derivatives | |
TW200508207A (en) | New benzimidazole derivatives | |
NO20070837L (no) | Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer. | |
SE0302573D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0301699D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0302570D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
ATE402166T1 (de) | Substituierte-1-phthalazinamine als vr-1- antagonisten | |
SE0302572D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
EA200600022A1 (ru) | Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций | |
DE60119514D1 (de) | Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentansäure |